{"filing":{"accession_number":"0001628280-26-045885","cik":"0001688757","ticker":"ESTA","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"esta-20260629.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828026045885/esta-20260629.htm"},"events":[{"id":14482,"run_id":12894,"accession_number":"0001628280-26-045885","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Taylor Harris was appointed to the Board of Directors of Establishment Labs effective June 24, 2026, and concurrently appointed to the Audit Committee and Nominating and Corporate Governance Committee. Harris brings 25+ years of healthcare and medical technology experience, including prior CEO and CFO roles at major companies acquired for substantial valuations, making this a material governance event affecting board composition and expertise.","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","ticker":"ESTA","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":11939,"accession_number":"0001628280-26-045885","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Taylor Harris to the Board of Directors effective June 24, 2026, and his concurrent appointment to the Audit Committee and Nominating and Corporate Governance Committee. While the disclosure also mentions standard non-employee director compensation arrangements, the principal disclosed action is Harris taking a director role. Harris brings 25+ years of healthcare and medical technology experience, including prior CEO and CFO roles at companies acquired for substantial valuations, making this a material governance event affecting board composition and expertise.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T12:06:54.300001+00:00","company_name":"","ticker":null,"filing_date":""},{"id":11940,"accession_number":"0001628280-26-045885","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Taylor Harris to Establishment Labs' Board of Directors, announced via press release on June 29, 2026. Harris brings 25+ years of healthcare and medical technology experience, including prior CEO and CFO roles at major companies (Cutera, MyoKardia, Zeltiq, Thoratec) and current board service at Procept BioRobotics. The appointment of a director with substantial industry expertise and track record of value creation is material to investors' assessment of the company's governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T12:06:54.300001+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11939,"accession_number":"0001628280-26-045885","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Taylor Harris to the Board of Directors effective June 24, 2026, and his concurrent appointment to the Audit Committee and Nominating and Corporate Governance Committee. While the disclosure also mentions standard non-employee director compensation arrangements, the principal disclosed action is Harris taking a director role. Harris brings 25+ years of healthcare and medical technology experience, including prior CEO and CFO roles at companies acquired for substantial valuations, making this a material governance event affecting board composition and expertise.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T12:06:54.300001+00:00","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","ticker":"ESTA","filing_date":"2026-06-29"},{"id":11940,"accession_number":"0001628280-26-045885","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Taylor Harris to Establishment Labs' Board of Directors, announced via press release on June 29, 2026. Harris brings 25+ years of healthcare and medical technology experience, including prior CEO and CFO roles at major companies (Cutera, MyoKardia, Zeltiq, Thoratec) and current board service at Procept BioRobotics. The appointment of a director with substantial industry expertise and track record of value creation is material to investors' assessment of the company's governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T12:06:54.300001+00:00","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","ticker":"ESTA","filing_date":"2026-06-29"}]}